Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who completed the treatment period of Study LG-ECCL002~* Patients requiring continuous treatment for rheumatoid arthritis upon the investigator's discretion~* For childbearing female patients or surgically non-sterile male patients, those who agreed to avoid pregnancy using proper contraceptive methods during the study.~* Patients who made a voluntary decision to participate in this clinical study and gave a voluntary written consent to comply with all the instructions with full understanding after being informed of the study~Exclusion Criteria:~* Patients deemed difficult to participate in this extension study due to the adverse events which occurred in Study LG-ECCL002, upon the investigator's discretion at screening~* Patients with at least 10 swollen joints (out of the total 66 assessing joints) or at least 12 tender joints (out of the total 68 assessing joints) at screening~* Women in pregnancy or lactation, or patients planning to be pregnant during the study period~* Patients ineligible for this clinical study upon the investigator's discretion

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- LBEC0101 (Type: EXPERIMENTAL): Etanercept 50mg

Based on this trial design, predict the completion outcome and termination type (if applicable).